{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:26:03Z","timestamp":1779153963525,"version":"3.51.4"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Acute pancreatitis (AP) can result in significant morbidity and mortality. Its complications include persistent organ failure, necrosis, and death. Recurrent episodes of AP may also result in chronic pancreatitis (CP), a fibroinflammatory condition characterized by chronic pain and endocrine and exocrine failure. Despite improved supportive care, approved disease-modifying targeted therapies for AP or CP are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Mechanistic studies identify early pathways within acinar and ductal cells that lead to injury, providing potential therapeutic targets before necrosis and other complications develop. Sustained cytosolic calcium elevation drives premature enzyme activation and mitochondrial failure, maintained by store-operated calcium entry through Orai1. Calcium overload promotes increased mitochondrial permeability, ATP depletion, and necrotic cell death. Potential early interventions include Orai1 inhibition (CM4620\/Auxora with early-phase human safety data and phase 2b signals), mitochondrial pore inhibition (NIM811) and other mitochondrial protectants. When systemic inflammation escalates, preclinical containment targets include NLRP3 inflammasome signaling, neutrophil extracellular traps, damage-associated molecular pattern signaling (including HMGB1), and upstream cytokine shedding via ADAM17\/TACE. Pragmatic strategies under study, such as early high-energy feeding, test whether modifiable supportive inputs can shift early severity trajectories. In chronic pancreatitis, long-term disease modification centers on targeting pancreatic stellate cells, which are critical drivers of fibrosis. Furthermore, the highly morbid chronic pain of CP can be modified through treatment of neuroimmune pain sensitization. The emerging clinical pipeline includes repurposed anti-fibrotic or immunomodulatory agents (pirfenidone, paricalcitol, tocilizumab, proglumide), genotype-matched therapy (CFTR modulation in selected populations), and cell-based approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>The current targeted therapeutic landscape in pancreatitis is promising, but difficulties lie in trial enrichment as the timing of drug administration is critically dependent on the timeline of disease. Therefore, progress will depend on matching treatment timing to target biology, identifying patients using practical early severity and inflammatory features, and using endpoints that reflect disease modification (organ failure, necrosis, recurrence, fibrosis progression, pancreatic function, and pain trajectories). Trial designs matching these therapeutics to their target biology will help understand the real clinical value of mechanism-based regimens across the AP\u2013RAP\u2013CP continuum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphys.2026.1795419","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:36Z","timestamp":1773379596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted therapeutics for pancreatitis"],"prefix":"10.3389","volume":"17","author":[{"given":"Tareq","family":"Alsaleh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, AdventHealth Orlando","place":["Orlando, FL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"George","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, AdventHealth Orlando","place":["Orlando, FL, United States"]},{"name":"Pancreas Center, AdventHealth Orlando","place":["Orlando, FL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/MPA.0000000000001175","article-title":"Accelerating the drug delivery pipeline for acute and chronic pancreatitis","volume":"47","author":"Abu-El-Haija","year":"2018","journal-title":"Pancreas"},{"key":"B2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.34172\/aim.2022.25","article-title":"Magnesium sulfate for prevention of Post-ERCP-Pancreatitis: a randomized controlled trial","volume":"25","author":"Aletaha","year":"2022","journal-title":"Arch. Iran. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MPA.0000000000002044","article-title":"Treatment of microcirculatory disturbances in acute pancreatitis: where are we now?","volume":"51","author":"Antkowiak","year":"2022","journal-title":"Pancreas"},{"key":"B4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.pan.2025.01.004","article-title":"Safety, tolerability and therapeutic efficacy of anti-inflammatory drug pirfenidone in acute pancreatitis patients: protocol for a randomized pilot clinical trial","volume":"25","author":"Bava","year":"2025","journal-title":"Pancreatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2017.10.012","article-title":"Mitochondrial dysfunction, through impaired autophagy, leads to endoplasmic reticulum stress, deregulated lipid metabolism, and pancreatitis in animal models","volume":"154","author":"Biczo","year":"2018","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/MPA.0000000000001793","article-title":"Auxora for the treatment of patients with acute pancreatitis and accompanying systemic inflammatory response syndrome: clinical development of a calcium release-activated calcium channel inhibitor","volume":"50","author":"Charles","year":"2021","journal-title":"Pancreas"},{"key":"B7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2019.11.128","article-title":"A small-molecule activator of mitochondrial aldehyde dehydrogenase 2 reduces the severity of cerulein-induced acute pancreatitis","volume":"522","author":"Cao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MPG.0000000000001788","article-title":"Reduction of recurrence risk of pancreatitis in cystic fibrosis with ivacaftor: case series","volume":"66","author":"Carrion","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/bjs.5251","article-title":"Blockade of interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute pancreatitis in vivo","volume":"93","author":"Chao","year":"2006","journal-title":"Br. J. Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1097\/CCM.0000000000001639","article-title":"Effects of tocilizumab on experimental severe acute pancreatitis and associated acute lung injury","volume":"44","author":"Chen","year":"2016","journal-title":"Crit. Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/pharmaceutics16050611","article-title":"The role of a cholecystokinin receptor antagonist in the management of chronic pancreatitis: a phase 1 trial","volume":"16","author":"Ciofoaia","year":"2024","journal-title":"Pharmaceutics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3390\/nu17152390","article-title":"Targeting oxidative stress in acute pancreatitis: a critical review of antioxidant strategies","volume":"17","author":"Coman","year":"2025","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13063-023-07287-z","article-title":"Effects of a peripherally acting \u00b5-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)","volume":"24","author":"Cook","year":"2023","journal-title":"Trials"},{"key":"B14","doi-asserted-by":"publisher","first-page":"174197","DOI":"10.1016\/j.ejphar.2021.174197","article-title":"GSK-7975A, an inhibitor of Ca2+ release-activated calcium channels, depresses isometric contraction of mouse aorta","volume":"906","author":"De Moudt","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","article-title":"Neural plasticity in pancreatitis and pancreatic cancer","volume":"12","author":"Demir","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ceca.2012.11.005","article-title":"The action of selective CRAC channel blockers is affected by the orai pore geometry","volume":"53","author":"Derler","year":"2013","journal-title":"Cell Calcium"},{"key":"B17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cgh.2011.11.024","article-title":"Reduced cortical thickness of brain areas involved in pain processing in patients with chronic pancreatitis","volume":"10","author":"Fr\u00f8kj\u00e6r","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19105","DOI":"10.1038\/s41598-020-76095-1","article-title":"Hic-5 is required for activation of pancreatic stellate cells and development of pancreatic fibrosis in chronic pancreatitis","volume":"10","author":"Gao","year":"2020","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1279539","DOI":"10.3389\/fimmu.2023.1279539","article-title":"Immune response mechanisms in acute and chronic pancreatitis: strategies for therapeutic intervention","volume":"14","author":"Glaubitz","year":"2023","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337154","article-title":"Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial)","author":"Guilabert","year":"2026","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pan.2025.03.001","article-title":"Tocilizumab for painful chronic pancreatitis (TOPAC trial): protocol for a phase 2 randomized, placebo-controlled, double-blind, investigator-initiated trial","volume":"25","author":"Hagn-Meincke","year":"2025","journal-title":"Pancreatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"968639","DOI":"10.3389\/fimmu.2022.968639","article-title":"Endoplasmic reticulum stress promoted acinar cell necroptosis in acute pancreatitis through cathepsinB-mediated AP-1 activation","volume":"13","author":"Han","year":"2022","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/10715762.2022.2163244","article-title":"Deoxyarbutin attenuates severe acute pancreatitis via the HtrA2\/PGC-1\u03b1 pathway","volume":"56","author":"Li","year":"2022","journal-title":"Free Radic. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41420-023-01550-7","article-title":"The trigger for pancreatic disease: NLRP3 inflammasome","volume":"9","author":"Liu","year":"2023","journal-title":"Cell Death Discov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20150425","DOI":"10.1098\/rstb.2015.0425","article-title":"Ca2+ toxicity and mitochondrial damage in acute pancreatitis: translational overview","volume":"371","author":"Mal\u00e9th","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1172\/JCI38674","article-title":"Impaired autophagic flux mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute pancreatitis","volume":"119","author":"Mareninova","year":"2009","journal-title":"J. Clin. Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e015874","DOI":"10.1136\/bmjopen-2017-015874","article-title":"High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial","volume":"7","author":"M\u00e1rta","year":"2017","journal-title":"BMJ Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2020.20317","article-title":"Acute pancreatitis: a review","volume":"325","author":"Mederos","year":"2021","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1053\/j.gastro.2015.08.026","article-title":"Neutrophil extracellular traps induce trypsin activation, inflammation, and tissue damage in mice with severe acute pancreatitis","volume":"149","author":"Merza","year":"2015","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gut.50.4.535","article-title":"Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis","volume":"50","author":"Mews","year":"2002","journal-title":"Gut"},{"key":"B31","volume-title":"IMPACT study: intervention monitoring for pancreatitis in an adolescent undergoing clinical treatment.","author":"Mission","year":"2025"},{"key":"B32","volume-title":"Tocilizumab for painful chronic pancreatitis: a randomised, placebo-controlled, double-blinded, investigator initiated trial (TOPAC trial).","author":"Olesen","year":"2024"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.1097\/PR9.0000000000000625","article-title":"Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment","volume":"2","author":"Olesen","year":"2017","journal-title":"Pain Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.3390\/ijms21114005","article-title":"Intracellular Ca2+ signalling in the pathogenesis of acute pancreatitis: recent advances and translational perspectives","volume":"21","author":"Pallagi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1113\/JP282203","article-title":"Bile acid- and ethanol-mediated activation of Orai1 damages pancreatic ductal secretion in acute pancreatitis","volume":"600","author":"Pallagi","year":"2022","journal-title":"J. Physiol."},{"key":"B36","first-page":"3943","article-title":"The effects of glycyrrhizin on acute pancreatitis in mice","volume":"18","author":"Pan","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B37","volume-title":"A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis.","author":"Pandol","year":"2025"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1006603","DOI":"10.1371\/journal.pgen.1006603","article-title":"Protecting cells by protecting their vulnerable lysosomes: identification of a new mechanism for preserving lysosomal functional integrity upon oxidative stress","volume":"13","author":"Pascua-Maestro","year":"2017","journal-title":"PLoS Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000540507","article-title":"The role of magnesium in acute pancreatitis and pancreatic injury: a systematic review","volume":"40","author":"Pergolini","year":"2024","journal-title":"Visc. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ceca.2011.02.010","article-title":"Aberrant Ca(2+) signalling through acidic calcium stores in pancreatic acinar cells","volume":"50","author":"Petersen","year":"2011","journal-title":"Cell Calcium"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1152\/physrev.00003.2021","article-title":"The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas","volume":"101","author":"Petersen","year":"2021","journal-title":"Physiol. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1097\/MPA.0000000000002333","article-title":"Interventions for pancreatitis - new approaches, knowledge gaps, and research opportunities: summary of a national institute of diabetes and digestive and kidney diseases workshop","volume":"53","author":"Phillips","year":"2024","journal-title":"Pancreas"},{"key":"B43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/biology10050384","article-title":"The unfolded protein response: an overview","volume":"10","author":"Read","year":"2021","journal-title":"Biol. (Basel)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2213744119","DOI":"10.1073\/pnas.2213744119","article-title":"Blockade of the protease ADAM17 ameliorates experimental pancreatitis","volume":"119","author":"Saad","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.3748\/wjg.v12.i47.7666","article-title":"Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis","volume":"12","author":"Sawa","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00535-008-2249-7","article-title":"Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis","volume":"43","author":"Shimizu","year":"2008","journal-title":"J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: a review","volume":"322","author":"Singh","year":"2019","journal-title":"JAMA."},{"key":"B49","first-page":"S64","article-title":"A randomized, double-blind, placebo-controlled dose-ranging study of auxora in patients with acute pancreatitis and accompanying systemic inflammatory response syndrome (SIRS): CARPO (NCT04681066) (late-breaking abstract)","volume":"119","author":"Sutton","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e167645","DOI":"10.1172\/jci.insight.167645","article-title":"Orai1 calcium channel inhibition prevents progression of chronic pancreatitis","volume":"8","author":"Szab\u00f3","year":"2023","journal-title":"JCI Insight"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1440-1746.2007.05206.x","article-title":"Pancreatic stellate cells: new target in the treatment of chronic pancreatitis","volume":"23","author":"Talukdar","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1113\/JP278517","article-title":"Novel mitochondrial transition pore inhibitor N-methyl-4-isoleucine cyclosporin is a new therapeutic option in acute pancreatitis","volume":"597","author":"T\u00f3th","year":"2019","journal-title":"J. Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/MPA.0000000000000713","article-title":"Chronic pancreatitis in the 21st century - research challenges and opportunities","volume":"45","author":"Uc","year":"2016","journal-title":"Pancreas"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1077414","DOI":"10.3389\/fimmu.2022.1077414","article-title":"Fire in the belly: a scoping review of the immunopathological mechanisms of acute pancreatitis","volume":"13","author":"Venkatesh","year":"2022","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1113\/JP277856","article-title":"The orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis","volume":"597","author":"Waldron","year":"2019","journal-title":"J. Physiol."},{"key":"B57","volume-title":"A phase I study evaluating safety and tolerability of autologous bone marrow-derived mesenchymal stromal cells in chronic pancreatitis patients who undergo total pancreatectomy and islet autotransplantation.","author":"Wang","year":"2022"},{"key":"B58","unstructured":"Autologous Mesenchymal Stromal Cells and Islet Co-Transplantation to Enhance Islet Survival and Function in Chronic Pancreatitis Patients Undergo Total Pancreatectomy and Islet Autotransplantation. clinicaltrials.gov\n          \n          \n            \n              Wang\n              H.\n            \n          \n          \n          2025"},{"key":"B59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sctm.17-0139","article-title":"Autologous mesenchymal stem cell and islet cotransplantation: safety and efficacy","volume":"7","author":"Wang","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1080\/15548627.2019.1596486","article-title":"Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/s41401-023-01139-x","article-title":"Decreased syntaxin17 expression contributes to the pathogenesis of acute pancreatitis in murine models by impairing autophagic degradation","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"B62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2015.04.015","article-title":"Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models","volume":"149","author":"Wen","year":"2015","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"113840","DOI":"10.3748\/wjg.v31.i48.113840","article-title":"Mitochondrial dysfunction as a bridge to pathology in acute pancreatitis: from molecular insights to novel therapeutic strategies","volume":"31","author":"Xia","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.mpa.0000236741.15477.8b","article-title":"Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis","volume":"33","author":"Yasuda","year":"2006","journal-title":"Pancreas"},{"key":"B65","doi-asserted-by":"publisher","first-page":"102281","DOI":"10.1016\/j.ceca.2020.102281","article-title":"Distinct pharmacological profiles of ORAI1, ORAI2, and ORAI3 channels","volume":"91","author":"Zhang","year":"2020","journal-title":"Cell Calcium"},{"key":"B66","doi-asserted-by":"publisher","first-page":"998035","DOI":"10.3389\/fgene.2023.998035","article-title":"Association between autophagy and acute pancreatitis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Genet."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1795419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:41Z","timestamp":1773379601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1795419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":66,"alternative-id":["10.3389\/fphys.2026.1795419"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2026.1795419","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"article-number":"1795419"}}